An exploratory randomised controlled trial comparing telephone and hospital follow-up after treatment for colorectal cancer by Beaver, Kinta et al.
Original article doi:10.1111/j.1463-1318.2012.02936.x
An exploratory randomized controlled trial comparing
telephone and hospital follow-up after treatment for colorectal
cancer
K. Beaver*, M. Campbell†, S. Williamson‡, D. Procter§, J. Sheridan§, J. Heath§ and S. Susnerwala–
*School of Health, University of Central Lancashire, Preston, UK, †School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK,
‡School of Health, University of Central Lancashire, Preston, UK, §Surgical Directorate, Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, UK
and –Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK2
Received 8 September 2011; accepted 31 October 2011; Accepted Article online XX Xxxx 20XX4
Abstract
Aim Following treatment for colorectal cancer it is
common practice for patients to attend hospital clinics
at regular intervals for routine monitoring, although
debate persists on the benefits of this approach. Nurse-led
telephone follow-up is effective in meeting information
and psycho-social needs in other patient groups. We
explored the potential benefits of nurse-led telephone
follow-up for colorectal cancer patients.
Method Sixty-five patients were randomized to either
telephone or hospital follow-up in an exploratory ran-
domized trial.
Results The telephone intervention was deliverable in
clinical practice and acceptable to patients and health
professionals. Seventy-five per cent of eligible patients
agreed to randomization. High levels of satisfaction were
evident in both study groups. Appointments in the
hospital group were shorter (median 14.0 min)5 than
appointments in the telephone group (median 28.9 min).
Patients in the telephone arm were more likely to raise
concerns during consultations.
Conclusion Historical approaches to follow-up unsup-
ported by evidence of effectiveness and efficiency are not
sustainable. Telephone follow-up by specialist nurses may
be a feasible option. A main trial comparing hospital and
telephone follow-up is justified, although consideration
needs to be given to trial design and practical issues related
to the availability of specialist nurses at study locations.
Keywords Xxxxxx, Xxxxxx, Xxxxxx 6
What is new in this paper?
The study demonstrates that colorectal cancer patients do
not need to attend busy hospital outpatient clinics for
follow-up care. Specialist nurses can provide a quality
service with high levels of patient satisfaction by tele-
phoning patients at home and asking specific questions
about physical and psycho-social function.
Introduction
Colorectal cancer (CRC) is the third most common
cancer worldwide [1]. However, mortality rates have
generally declined across Europe [2], reflecting improve-
ments in treatment, detection of early stage cancers from
screening programmes and ⁄ or improved symptom rec-
ognition [3,4]. Hence, increasing numbers of people live
many years beyond diagnosis and treatment and need
information and support to resume normal activities. The
UK’s National Cancer Survivorship Initiative (NCSI) has
recognized the need to develop models of care that
ensure that the needs of cancer survivors are met;
improving self-care, care planning and making the best
use of resources and technology [5].
Following treatment for CRC it is common practice
for patients to return to hospital clinics at regular intervals
over a number of years for routine monitoring aimed at
detecting early recurrence. Debate has raged internation-
ally on whether there are survival benefits to follow-up
after curative CRC surgery, with little consensus on the
best combination of tests ⁄ investigations to maximize
outcome [6,7]. While work is ongoing to address these
issues, other aspects of survivorship demand attention.
Patients can be unaware that long-term side-effects are
associated with treatment and they experience a host of
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physical and psychological problems [8]. Stoma patients
may experience particular difficulties, with a negative
impact on body image and quality of life [9–11], while
debilitating bowel problems are also reported by patients
treated with sphincter-saving surgery [12].
Specialist nurses can deliver a quality follow-up service,
meeting psycho-social needs and providing adequate
support with high levels of patient satisfaction and no
physical or psychological detriment when compared with
traditional doctor-led follow-up [13–17]. A randomized
controlled trial (RCT) comparing hospital and nurse-led
telephone follow-up for breast cancer patients reported
positive findings in terms of satisfaction with service and
meeting information needs [13]. This approach could be
effective for CRC as the priority information needs of
patients with breast cancer and CRC are reportedly
similar [18]. Nurse-led telephone follow-up may reduce
the burden on busy outpatient clinics, but there is limited
evidence on the efficiency of these services. Economic
evaluations of telephone follow-up are few and present a
complex picture. Combining telephone follow-up with
an educational group programme may result in cost
savings [19], although telephone follow-up for breast
cancer patients can be more expensive than traditional
hospital follow-up if senior nurses spend longer on the
telephone than doctors in hospital clinics [20].
Complex interventions that evaluate psycho-social
and ⁄ or information-based approaches to care are difficult
to evaluate. Hence, we conducted a series of studies that
followed the Medical Research Council (MRC) Frame-
work for Development and Evaluation of RCTs for
complex interventions in health care [21]. Phase I
(theoretical) and Phase II (modelling) involved qualita-
tive and quantitative approaches that explored patient
views on follow-up service provision and clarified com-
ponents of the intervention [22,23]. This paper reports
on Phase III (exploratory trial), a crucial component prior
to a definitive RCT designed to test the delivery of the
telephone intervention. The aim of this exploratory trial
was to evaluate telephone follow-up, using a structured
intervention, in terms of psychological morbidity, meet-
ing information needs and satisfaction with information
and service. In addition, the study was designed to collect
data to determine appropriateness of inclusion ⁄ exclusion
criteria and outcome measures, the acceptability of the
intervention to patients and clinicians and the likely
consent rate for recruitment to a main trial.
Method
This randomized pilot trial compared hospital and nurse-
led telephone follow-up for patients treated for CRC. We
aimed to recruit approximately 60 patients, as recom-
mended when estimating a particular parameter in a pilot
study [24]. Eligible patients had a diagnosis of CRC, had
completed treatment (surgery ⁄ radiotherapy ⁄ chemother-
apy) with no evidence of recurrent disease, had access to a
telephone, adequate hearing and were attending hospital
outpatient consultations for routine monitoring. Recruit-
ment took place at a large hospital in the north-west of
England. Consecutive eligible patients were identified at
the hospital clinics of four consultant surgeons and a
colorectal nurse practitioner. The latter already provided
a service to patients after treatment at nurse-led clinics, an
expectation of the practitioner role. Clinical nurse
specialists provided a service to patients at the time of
diagnosis, on admission to hospital and at home follow-
ing hospital discharge, and stoma care nurses attended to
the needs of patients with a stoma. However, it was only
the nurse practitioner who was involved in delivering the
telephone intervention in this study. The study had
approval from the National Research Ethics Service.
Randomization
Consenting individuals were randomized to either hos-
pital or telephone follow-up by a computerized system.
Group allocation was stratified by age (£ 60 years,
> 60 years) and gender. Allocation sequences were con-
cealed until interventions were assigned. The analyst was
blind to study group allocation. Participants randomized
to the hospital arm were routinely reviewed at 6-weeks
posttreatment, then 6-monthly intervals for 2 years and
annually for a further 3 years and discharged to the care
of their general practitioner (GP) after 5 years, unless
complex or unresolved problems were evident. Hospital
consultations could be conducted by consultant sur-
geons, registrars, more junior doctors or a colorectal
nurse practitioner. The content and format of appoint-
ments in the hospital control arm was unaltered and
clinicians focused on routine monitoring for detection of
recurrent disease.
Participants randomized to telephone follow-up
received telephone consultations from a colorectal nurse
practitioner at the same prescribed intervals as partici-
pants in the hospital arm. Appointments were focused
primarily on provision of information using a structured
intervention to establish patient information needs.
Appointment cards were sent, indicating the date and
time of telephone appointments. These were registered
on computerized hospital information systems in the
same way as traditional hospital appointments so that
medical records staff could retrieve patient notes prior to
telephone clinics. Thirty minutes were allocated for
telephone appointments (20 min consultation time,
10 min administration), based on the mean time taken
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to deliver the telephone intervention in a previous trial of
telephone follow-up for breast cancer patients [13]. The
same nurse carried out all telephone consultations. As
with hospital appointments, telephone clinic appoint-
ments were reimbursed to the hospital by the health
authority.
Telephone intervention
The structured telephone intervention was developed
from previous work [13,18]. Questions were asked
relating to changes in condition, new or unresolved
symptoms, information requirements about spread of
disease, treatment and side-effects, genetic risk, sexual
attractiveness, sexual function, self-care (diet, problems
with wound ⁄ stoma, problems with bowels and urinary
function, support groups, finances) and family concerns.
All participants were asked if they had any other needs
and concerns. Standard protocols related to routine tests
and investigations (e.g. carcinoembryonic antigen blood
levels, CT scan, colonoscopy) were unaltered. Four half-
day sessions on the administration of the intervention
were given, with regular feedback and de-briefing sessions
throughout the study period. To monitor the integrity of
the intervention, all telephone consultations were audio-
recorded with patient consent. Any patient who pre-
sented with signs of recurrent disease (symptomatic or
outcome of tests ⁄ investigations) was referred back to a
hospital clinic and withdrawn from the telephone arm of
the study.
Measures
Primary outcomes included psychological morbidity,
meeting information needs and satisfaction with infor-
mation and service. Secondary outcomes related to
clinical investigations ordered, time to detection of
recurrent disease and costs to patients. At this exploratory
stage a formal economic evaluation was not conducted,
although data were collected on patient out-of-pocket
expenses.
Psychological morbidity was measured using the
State-Trait Anxiety Inventory (STAI) and the General
Health Questionnaire (GHQ). The STAI comprises 40
items measuring anxiety, differentiating between tempo-
rary anxiety (state, Y1) and long-standing anxiety
reflected as a personality trait (trait, Y2). The GHQ
focuses on a wider range of issues relating to psycholog-
ical morbidity; we used the shortened 12-item version
(GHQ-12) to minimize patient burden. Both tools are
self-administered and have been well validated [25,26].
Patient information needs and satisfaction levels were
recorded using questionnaires adapted from a survey of
CRC patients’ follow-up needs and a satisfaction measure
used in a lung cancer follow-up trial [16,23]. The items
comprised tick-box responses, five-point Likert satisfac-
tion and agreement scales and one overall satisfaction
rating scale (ranging from 1 to 10). Questions were asked
about health-care contacts between appointments and
out-of-pocket expenses. All questionnaires were admin-
istered at baseline and at one additional time point,
individually chosen to maximize the number of appoint-
ments that patients had between completion of measures.
To capture the benefits of immediate recall, question-
naires were posted shortly after scheduled appointments.
Clinical outcomes for the hospital arm were recorded
using a ‘record of visit’ form, including details on
who patients saw at consultations, tests ⁄ investigations
ordered, referrals made, clinical examinations conducted
and indications of recurrent disease. For the telephone
group the nurse completed an intervention guide on
areas of concern discussed during telephone consulta-
tions, tests ⁄ investigations ordered, referrals made and
any indications of recurrent disease. This information was
cross-checked by a researcher who listened to telephone
consultation recordings and completed a proforma sim-
ilar to the intervention guide. Any confirmed disease
recurrences were closely monitored through hospital
records and consultation with clinical staff. At study end
a retrospective examination was made of all participants’
case notes to check the accuracy of clinical data.
Statistical analysis
Analysis was by intention-to-treat. As this was a pilot
study, analyses were mainly descriptive, and estimation of
recruitment, protocol violation, attrition and data com-
pletion rates were important. Analysis of covariance was
used to compare STAI, GHQ-12 and satisfaction with
appointment scores at follow-up by group adjusted for
baseline scores and estimate 95% confidence intervals for
differences in adjusted means. The unpaired t-test was
also used to compare satisfaction with appointment scores
at follow-up by group, given that those in the telephone
group had a different kind of appointment at follow-up.
Fisher’s exact test was also used to compare categorical
outcomes by group. The results of any inferential
comparisons should be interpreted with caution given
that the study was not powered to detect statistically
significant differences.
Results
Figure 1 shows the flow of participants through the trial.
Ninety-eight patients were eligible for inclusion although
eight had either not attended their appointments as
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scheduled or were missed by researchers. The study was
discussed with the remaining 90 patients; 65 consented
to participate (72%). Of 65 patients randomized, only
three did not receive the intervention as allocated and 15
(23%) were lost to follow-up (Fig. 1). Patients remained
in the study from 8 to 15 months (mean 12 months). A
typical participant was male (58%), married (64%) and
retired from work (88%). Participants were a mean of
21 months from diagnosis and groups were reasonably
balanced at baseline (Table 1).
Eight participants from the hospital arm (24%) and
seven from the telephone arm (22%) did not provide
follow-up data (Fig. 1). The four men and two women in
the hospital arm who did not return questionnaires were
Notes assessed for eligibility in hospital clinics (n = 3066)  
 Clinic sessions attended for recruitment (n =123)   
Patients treated for colorectal cancer identified (n = 206)  
Excluded (n = 141) 
Not meeting inclusion criteria (n = 108) 
Declined to participate (n = 25) 
Did not attend appointment (n = 6)  
Missed by researchers (n = 2)
Analysed (n = 25) 
Excluded from analysis due to incomplete data 
Incomplete STAI Y1, Y2 at baseline, Y1 at
follow-up (n = 13)  
Incomplete GHQ total at baseline and
follow-up (n = 2)  
Lost to follow-up (n = 8) 
Distant recurrence of cancer (n = 2) 
Did not return questionnaire (n = 6) 
Allocated to intervention (n = 33) 
Received allocated intervention (n = 31)
Did not receive allocated intervention (n = 2) 
Inconvenient coming up to hospital
(requested telephone follow-up)  
Lost to follow-up (n = 7) 
Distant recurrence of cancer (n = 1) 
Patient request (n = 2) 
Health professional request (n = 3) 
Died (n = 1) 
Allocated to intervention (n = 32) 
Received allocated intervention (n = 31)
Did not receive allocated intervention (n = 1) 
Patient unclear about appointments
Analysed (n = 25) 
Excluded from analysis due to incomplete data 
Incomplete STAI Y1, Y2 at baseline, Y1 at 
follow-up (n = 10) 
Incomplete GHQ total at baseline and
follow-up (n = 5)  
Missing satisfaction with most recent follow-up
appointment (n = 2) 
Incomplete details of first and subsequent
appointment (n = 1)  
Allocation
Analysis
Follow-up
Randomised (n = 65) 
Enrollment
Hospital group Telephone group 
ƒ
ƒ
ƒ
ƒ
ƒ
ƒ
•
•
•
•
•
•
•
•
•
•
•
•
•
•
ƒ
ƒ
Figure 1 Flow of participants through the pilot trial [STAI, State-Trait Anxiety Inventory (Y1, temporary anxiety state; Y2, personality
trait); GHQ-12, General Health Questionnaire (shortened 12-item version)].
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slightly younger (mean age 69 years) and not as far from
diagnosis (mean 11 months). The one death recorded
during the study was unrelated to CRC. Three partici-
pants (two hospital, one telephone) changed group
during the study.
Not all participants provided complete data on the
primary outcome measures. Only 12 (48%) hospital and
15 (60%) telephone participants provided complete data
on the STAI at baseline and follow-up. No particular item
appeared to give participants a problem. However, five
hospital and one telephone participant answered at least
19 of the 20 ‘state’ (Y1) questions but none of the 20
‘trait’ (Y2) questions at baseline. All but one of these
participants answered at least 19 ⁄ 20 ‘state’ questions at
follow-up. Responses to the GHQ-12 were better: 23
(92%) hospital and 20 (80%) telephone participants
provided complete data (Table 2). Mean and median
scores for STAI state anxiety were appreciably higher in
the hospital arm at follow-up (Cohen’s d = 0.66), and
mean GHQ-12 score was slightly higher (Cohen’s
d = 0.11). There were no significant differences between
groups at follow-up in STAI (P = 0.297) or GHQ-12
(P = 0.626).
Questions on information needs were answered by the
majority at baseline and follow-up. Information about
genetic risk and self-care were the most common infor-
mation needs in each group at baseline (Table 3). By
follow-up, this was still true for the telephone arm and at
the same level. However, in the hospital arm information
about genetic risk and sexual attractiveness were the most
common needs but at a reduced level. The most
noticeable difference between groups was the number
of information needs raised by participants: in the
telephone arm, 33 needs were raised at baseline and 30
at follow-up; in the hospital arm 32 were raised at
baseline but only 16 were raised at follow-up. Only three
Table 1 Baseline characteristics of participants.
Characteristic
Hospital group
(n = 25)
Telephone
group (n = 25)
Mean SD Mean SD
Age (years) 72.4 8.2 73.6 7.6
Number % Number %
Aged over 60 22 88 22 88
Gender
Male 13 52 16 64
Female 12 48 9 36
Marital status
Married ⁄ cohabiting 17 68 15 60
Divorced ⁄ separated 2 8 4 16
Widowed 5 20 4 16
Never married 1 4 2 8
Retired from work 22 88 22 88
Mean SD Mean SD
Time from diagnosis
(months)
18.7 14.4 22.4 16.1
Time from first post-
treatment visit (months)
12.3 15.3 17.0 16.0
Number % Number %
Surgery 25 100 25 100
Radiotherapy 1 4 4 16
Chemotherapy 9 36 5 20
Cancer location
Colon 17 68 12 48
Rectum 8 32 13 52
Stoma
Permanent 5 20 9 36
Temporary 0 0 1 4
Stoma now reversed 2 8 5 20
No stoma 18 72 10 40
Table 2 Psychological morbidity by randomization group.
Measure
Hospital group (n = 25) Telephone group (n = 25)
No. Mean SD Median Range No. Mean SD Median Range
Baseline
STAI Y1 12 29.0 8.9 25 20–47 15 28.5 8.1 27 20–42
STAI Y2 12 35.9 13.2 32 22–63 15 31.3 10.8 29 20–53
GHQ-12 total 23 1.4 1.8 1 0–6 20 1.5 2.3 0 0–6
Follow-up
STAI Y1* 12 36.0 17.4 31 20–73 15 27.9 9.8 24 20–50
GHQ-12 total 23 1.3 2.7 0 0–10 20 1.0 2.9 0 0–12
STAI, State-Trait Anxiety Inventory (Y1, temporary anxiety state; Y2, personality trait); GHQ-12, General Health Questionnaire
(shortened 12-item version).
*Analysis of covariance: F = 1.14, d.f. = 1 and 23, P = 0.297; 95% CI for difference between adjusted means )3.5 to 11.1
Analysis of covariance: F = 0.24, d.f. = 1 and 40, P = 0.626; 95% CI for difference between adjusted means )1.1 to 1.8
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participants reported ‘other’ information needs. One
participant wanted information about bowel function,
which was included in the intervention, and two did not
specify information needed.
Satisfaction with the most recent appointment was
scored by all 50 participants at baseline and by all those in
the hospital arm and 23 of those in the telephone arm at
follow-up (Table 4). The mean score for satisfaction with
Table 3 Information needs by randomization group.
Baseline Follow-up
Hospital group
(n = 25)
Telephone group
(n = 25)
Hospital group
(n = 25)
Telephone group
(n = 25)
No. of
responses
No. with
need %
No. of
responses
No. with
need %
No. of
responses
No. with
need %
No. of
responses
No. with
need %
Information about the
disease and whether
it had spread
24 4 17 21 4 19 23 1 4 21 3 14
Information about the
different types of
treatment, including
side-effects
24 4 17 21 4 19 23 2 9 24 3 13
Information about whether
children or other family
members are at risk
23 10 43 21 8 38 23 5 22 24 7 29
Information about how
treatment may have
affected feelings about
body andsexual
attractiveness
23 4 17 20 6 30 22 5 23 23 4 17
Information about caring
for self
23 9 39 21 8 38 23 3 13 24 8 33
Concerns about how
family are coping with
diagnosis
24 0 0 21 2 10 23 0 0 23 3 13
Other information required 21 1 4 17 1 6 22 0 0 22 2 10
Table 4 Satisfaction with service and information provision by randomization group.
Baseline Follow-up
Hospital group
(n = 25)
Telephone group
(n = 25)
Hospital group
(n = 25)
Telephone group
(n = 25)
No. of
responses Mean SD
No. of
responses Mean SD
No. of
responses Mean SD
No. of
responses Mean SD
Satisfaction with most
recent appointment*,
25 9.0 1.1 25 8.7 1.8 25 9.5 0.8 25 9.8 0.5
n % n % n % n %
Received all ⁄most
information needed
23 22 96 22 21 95 25 25 100 23 23 100
Had concerns or problems 24 7 29 23 8 35 23 3 13 25 5 20
Mentioned concerns 10 8 80 11 7 64 7 3 43 10 9 90
Very satisfied ⁄ satisfied with
way concerns were addressed
12 11 92 14 13 93 11 11 100 18 17 94
*At follow-up, unpaired t-test: t = )1.66, d.f. = 39.6, P = 0.104; 95% CI for difference between means )0.7 to 0.7.
At follow-up, analysis of covariance: F = 5.08, d.f. = 1 and 45, P = 0.029; 95%CI for difference between adjustedmeans )0.8 to )0.04.
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the most recent appointment was higher in the telephone
arm (Cohen’s d = 0.45). Unadjusted for baseline scores,
there was no evidence of a difference in satisfaction
between groups at follow-up (P = 0.104); adjusted for
baseline scores, satisfaction was higher in telephone
follow-up (P = 0.029). The most noticeable difference
between the groups was in the mentioning of concerns at
the follow-up appointment: 3 ⁄ 7 hospital participants
who answered the question did so compared with 9 ⁄ 10
telephone participants, although the difference was not
statistically significant (Fisher’s exact P = 0.101).
The two groups were similar at baseline in terms of
numbers of contacts between appointments with health
professionals in the previous 6 months. The groups were
also similar at follow-up, with fewer contacting a GP or
hospital doctor. In the hospital arm, nine had contacted a
GP, ten a colorectal nurse and one a hospital doctor; in
the telephone arm the numbers were eight, thirteen and
three respectively. There were no noticeable differences in
the numbers of participants in the two groups in terms of
blood tests or colonoscopies ordered, although CT scans
were more likely to be ordered in the hospital (14 ⁄ 25,
56%) than the telephone (10 ⁄ 24, 42%) arm. The
difference was not statistically significant but the sample
size was small.
There was a clear difference between groups for
duration of appointment. Themedian duration of hospital
appointments was 14.0 min (range 2.3–58.0) compared
with a median of 28.9 min (range 6.1–48.37 ; Mann–
Whitney U = 136.0, P = 0.001) for telephone appoint-
ments. Within the hospital arm, a nurse conducted 12 of
the face-to-face appointments (median 24.0 min, range
8.8–33.0) and two telephone appointments (34.6 and
58.0 min); the other 11 appointments were with hospital
doctors (median 4.0 min, range 2.3–13.8).
Two hospital participants and one telephone partici-
pant had a recurrence during the study. All three
occurred in asymptomatic male patients and were
detected by routine investigations ordered at hospi-
tal ⁄ telephone appointments (CT scan in all cases). Time
to detection of recurrence was estimated based on
the date on which the scan showed an abnormality to
the date the patient was informed of the diagnosis of
recurrence. For the telephone participant (age 72 years) it
was 8 weeks to confirmation of metastases in a retrocaval
node. For the two hospital participants, time to detection
of recurrence was 7 weeks for one individual with lung
metastases (81 years) and 8 weeks for an individual with
liver metastases (59 years).
At baseline, patients reported that it took a median of
22.5 min (range 10–60) to get to the hospital appoint-
ment from home. For the hospital arm this was similar at
the follow-up time point (median 30 min).8 The majority
reported travelling to hospital appointments in their own
car or a friend’s ⁄ relative’s car (63.1% at baseline, 65.2%
for the hospital arm at follow-up). Other forms of
transport included bus, taxi and hospital transport. For
those who used public transport the cost was reported as
a median of £3 (€3.42) at baseline (range £1–18, €1.14–
20.51) and £8 (€9.11) at follow-up (range £5–11, €5.70–
12.53). Only four participants reported having to take
time out of work for their hospital appointments at
baseline and one at the follow-up time point. However,
the majority reported being accompanied to hospital
appointments by a relative ⁄ friend at baseline (73.9%),
slightly reduced at follow-up (56.5%).
Discussion
This study demonstrates that telephone follow-up by
specialist nurses is an acceptable and feasible approach to
providing follow-up care for CRC patients and inclusion
criteria appear appropriate. The intervention was relevant;
no questions were considered redundant or unsuitable.
Early indications are that telephone follow-up can be
successfully incorporated into clinical practice within
current resources. While the best combination of tests
and investigations for maximizing patient outcomes
remains unclear, telephone follow-up is one means of
meeting psycho-social needs and providing patients with
the information and support they need to live well
following diagnosis.
Although it is unlikely that specialist nurses could
provide follow-up care for all patients on completion of
treatment, they could take responsibility for a significant
cohort who had a preference for being telephoned at
home. In this study 75% agreed to randomization,
indicating that patients were agreeable to their consulta-
tion being carried out by a specialist nurse rather than a
doctor. A recent study comparing nurse- and doctor-led
follow-up after rectal cancer surgery found that patient
satisfaction was equally as high for nurses and doctors
[27]. If telephone support is equivalent to hospital
support, with no physical or psychological detriment,
then a negotiated approach offering patients a choice of
follow-up care provision could be introduced.
Outcome measures appeared to be appropriate,
although there were missing data for ‘trait’ (Y2) ques-
tions on STAI. We are not clear why this was the case and
may have resulted from administrative error; more
detailed records would need to be kept in any future
trial. Participants did not have raised anxiety levels if they
were telephoned, foregoing face to face contact with a
hospital doctor. This would justify a RCT with a non-
inferiority or equivalence design in future research.
Telephone participants raised more concerns. Arguably,
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information needs were met at hospital visits and there-
fore patients did not have any concerns. Alternatively,
patients may not have been comfortable raising concerns
in busy hospital clinics. If clinicians rely on patients to
initiate discussion of psycho-social issues then problems
may not be addressed [28].
Appointments with a nurse were longer than appoint-
ments with a doctor, irrespective of study group. Appoint-
ments with hospitals doctors were of short duration (mean
4.8 min).9 This clearly has cost implications. Although
patients in the telephone group saved time and travelling
costs, more evidence is needed on whether this is a cost-
effective approach for the health service. It was more likely
that patients would mention their concerns during tele-
phone consultations, probably as a result of being asked
specific questions, and this may have extended consulta-
tions. As this was a pilot study, patients were not followed
up over an extended time period, and we are uncertain if
appointment duration reduces over time once nurses are
familiar with the intervention and initial concerns and
information needs are addressed.
A limitation of the study was that the same nurse
conducted some of the hospital appointments and all the
telephone appointments. Although the nurse only used
the structured telephone intervention with patients ran-
domized to the telephone arm, contamination is possible
and would need to be avoided in a main trial. Resources
were not available to carry out a multicentre study with a
number of different specialist nurses. However, there was
value in one nurse being involved in both arms of the
study at the pilot stage in providing useful feedback on
the two approaches and training requirements to inform
the main study. A design that involves sequential rollout
of the intervention may be a suitable and practical design
if there is a shortfall in the number of nurses required to
eliminate contamination between study groups.
In the current economic climate it is unlikely we can
sustain historical approaches to follow-up that are not
supported by evidence of effectiveness and efficiency. The
telephone intervention was acceptable to both patients
and health professionals and was deliverable in practice. A
main trial of the intervention is justified with an economic
evaluation, preferably with an equivalence or non-inferi-
ority design.
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